From Our Writers

For the second time this year, the U.S. House of Representatives has approved the SAFE Banking Act which would allow banks to work with cannabis firms without fear of penalty.

Only 47 of Maine’s 500 towns and cities—comprising about 29% of the state’s population—permit any adult-use cannabis industry operations.

A Pennsylvania bill aims to protect the state’s medical cannabis patients from DUI charges, treating medical cannabis the same as any other prescription medication.

Beginning October 1, medical cannabis patients in Connecticut can grow six plants individually with a maximum of 12 per household.

California-based Catalyst Cannabis Co. filed a lawsuit last week against the state’s Department of Cannabis Control over product diversion due to high tax rates.

California’s attorney general last week approved language for an upcoming psychedelic decriminalization ballot initiative.

New Jersey cannabis regulators have missed the statutory deadline to begin accepting industry applications.

The Commercial Cannabis Production program at Niagara College has received a license to cultivate hemp from Health Canada, enabling a hands-on experience for students.

Researchers found that withdrawal effects from synthetic cannabinoids appear more rapidly with consumers reporting more severe symptoms of insomnia, irritation and bad mood, heart palpitations, and loss of appetite.

The campaign to decriminalize cannabis in Italy gathered the 500,000 signatures required to put the issue before voters in just one week.

The Nebraska Cannabis Association, launched last week, is the state’s first organization dedicated to lobbying for cannabis policy, advising on regulations, and supporting cannabis industry entrepreneurs.

Pennsylvania Lt. Gov. John Fetterman (D) is making cannabis legalization a centerpiece of his campaign for the U.S. Senate, saying “It’s always been the right thing to do.”

A referendum in Italy to decriminalize cannabis is on track to meet the 500,000 signatures it needs to be considered by lawmakers before the September 30 deadline.

The Delaware Supreme Court last week ruled that cannabis odor during a traffic stop by itself is not enough to trigger probable cause for arrest.

Missouri officials transferred more than $6.8 million of the state’s $8.9 million in cannabis tax revenue to the Veterans Commission, as required under the state’s medical cannabis law.

Three New Hampshire legislators have filed separate proposals to put adult-use cannabis constitutional amendment questions on the 2022 ballot.

President Biden received a letter this week signed by more than 150 celebrity entertainers, politicians, law enforcement officials, and advocates requesting clemency for federal cannabis offenders.

Since July, New Jersey courts have expunged at least 362,000 low-level cannabis-related criminal records and there are an estimated 125,000 to 150,000 similar cases that could be automatically expunged under the state’s legalization law.

South Dakota approved most of the Department of Health’s rules for the state’s voter-approved medical cannabis program but rejected some proposals including limiting patient possession of high-potency cannabis products.

The National Underwriter Company is launching the Cannabis Insurance Coverage Specialist program, one of the first certifications for insurance agents, risk managers, and other professionals who advise cannabis-related businesses.

The FDA and CDC issued warnings this week against consumer products containing hemp-derived delta-8 THC, which has yet to be thoroughly studied.

The World Anti-Doping Agency will review its cannabis policies following the suspension of Sha’Carri Richardson during the Summer Olympic Games after she tested positive for cannabis.

Michigan introduced a group of bipartisan bills that would reduce the number of patients allowed per medical cannabis caregiver from five to just one and also limit the amount of plants caregivers could grow from 60 to 12.

Pennsylvania officials will disclose for the first time how many of the state’s medical cannabis patients are certified as a treatment for opioid use disorder, as well as each of the state’s other qualifying conditions.